Clinical Trials
3 trialsNCT06357377 2026-01-14
A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
Neonc Technologies, Inc.
Phase 1 Not yet recruiting
NCT00022425 2013-12-18
Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00002862 2013-02-11
Perillyl Alcohol in Treating Patients With Refractory Cancer
National Cancer Institute (NCI)
Phase 1 Completed